🔬 Health & Fitness Research
FDA clearance in cardiac algorithms is surging (120+ cleared, $300M in acquisitions), but the volume is clinical imaging sold to hospitals, not consumer wearables. Apple Watch, Fitbit Sense, Samsung Galaxy Watch, and Withings ScanWatch already ship FDA-cleared AFib detection; when those hospital vendors get acquired, licensing to watch makers just extends the existing pipeline from 2018.
Marty’s Take:
The math is telling: $300M in AI cardiovascular investment against 120+ FDA-cleared algorithms means clinical-grade heart monitoring is migrating from hospital devices into consumer hardware faster than most buyers realize. Anyone shopping now should treat arrhythmia detection accuracy as a spec worth comparing, not an afterthought. Check the current field in our best fitness tracker guide.
Shop mentioned gear: Apple Watch | Withings ScanWatch | Samsung Galaxy Watch | Fitbit Sense
Source: Yahoo Finance / BCC Research
Related Reviews
